Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Oxford Genetics, Twist Bioscience Partner to Produce Synthetic DNA | Contract Pharma
Breaking News

Oxford Genetics, Twist Bioscience Partner to Produce Synthetic DNA

The new licensing agreement will help reach customers who order smaller quantities of genes

Oxford Genetics, a provider of synthetic based technologies for biologics discovery, development, and delivery, has entered a new licensing agreement with Twist Bioscience Corporation, a producer of rapid synthetic DNA. Under the deal, Oxford Genetics will supply Twist Bioscience with its SnapFast technology platform to provide a broad range of application-specific expression vectors, which Twist Bioscience will then use to clone synthesized DNA.
 

The SnapFast technology will allow Twist Bioscience to switch between all of Oxford Genetics’ vectors, making future changes and additions simple and efficient.

“By utilizing our SnapFast™ platform, Twist Bioscience is giving its customers access to the latest vector designs for the most demanding applications and providing them with better value, a streamlined workflow and maximum flexibility in order to utilize their custom DNA constructs to their best effect.” said Dr Ryan Cawood, chief executive officer of Oxford Genetics.

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters